Tuesday, February 27, 2018

New advances in medication for muscle disease in children

Spinraza, the gene therapy medication, also provides significant improvements in cases with the next most severe form of neuromuscular disease, spinal muscular atrophy (SMA), which afflicts children from 6 to 18 months of age.

from Top Health News -- ScienceDaily http://ift.tt/2GM4vIf

No comments:

Post a Comment

A common vitamin could influence bathroom frequency

Scientists studying genetic data from over a quarter million people have uncovered new clues about what controls how fast the gut moves. The...